Medscape. May 08, 2013
SAN DIEGO, California — A genetic test can predict the aggressiveness of prostate cancer, a new study shows.
The 17-gene test predicts whether tumors will progress to high-grade or postsurgical stage III disease.
"We think this will allow patients and doctors to make more confident decisions," study coauthor Eric Klein, MD, told Medscape Medical News. "That will be a boon to everyone and it will save the system money."
The results of the study were presented here at the American Urological Association 2013 Annual Scientific Meeting.
Read the full Medscape report
(Free sign-up may be required)
